75 related articles for article (PubMed ID: 8904203)
1. Presence of functional P2T and P2U purinoceptors on the human megakaryoblastic cell line, Meg-01 characterization by functional and binding studies.
Hechler B; Cazenave JP; Hanau D; Gachet C
Nouv Rev Fr Hematol (1978); 1995; 37(4):231-40. PubMed ID: 8904203
[TBL] [Abstract][Full Text] [Related]
2. Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts.
Sistare FD; Rosenzweig BA; Contrera JG; Jordan B
J Pharmacol Exp Ther; 1994 Jun; 269(3):1049-61. PubMed ID: 8014849
[TBL] [Abstract][Full Text] [Related]
3. Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.
Murgo AJ; Contrera JG; Sistare FD
Blood; 1994 Mar; 83(5):1258-67. PubMed ID: 8118030
[TBL] [Abstract][Full Text] [Related]
4. Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.
Shi XP; Yin KC; Gardell SJ
Thromb Res; 1995 Feb; 77(3):235-47. PubMed ID: 7740516
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the human P2Y13 receptor.
Marteau F; Le Poul E; Communi D; Communi D; Labouret C; Savi P; Boeynaems JM; Gonzalez NS
Mol Pharmacol; 2003 Jul; 64(1):104-12. PubMed ID: 12815166
[TBL] [Abstract][Full Text] [Related]
7. Characterization of P2 purinergic receptors on human erythro leukemia cells.
Akbar GK; Dasari VR; Sheth SB; Ashby B; Mills DC; Kunapuli SP
J Recept Signal Transduct Res; 1996; 16(3-4):209-24. PubMed ID: 8897312
[TBL] [Abstract][Full Text] [Related]
8. ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors.
Pubill D; Dayanithi G; Siatka C; Andrés M; Dufour MN; Guillon G; Mendre C
Cell Calcium; 2001 May; 29(5):299-309. PubMed ID: 11292387
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.
Takasaki J; Kamohara M; Saito T; Matsumoto M; Matsumoto S; Ohishi T; Soga T; Matsushime H; Furuichi K
Mol Pharmacol; 2001 Sep; 60(3):432-9. PubMed ID: 11502873
[TBL] [Abstract][Full Text] [Related]
10. Existence of P2-purinoceptors on human and porcine granulosa cells.
Kamada S; Blackmore PF; Oehninger S; Gordon K; Hodgen GD
J Clin Endocrinol Metab; 1994 Mar; 78(3):650-6. PubMed ID: 8126137
[TBL] [Abstract][Full Text] [Related]
11. K562 leukemia cells express P2T (adenosine diphosphate) purinergic receptors.
Murgo AJ; Sistare FD
J Pharmacol Exp Ther; 1992 May; 261(2):580-5. PubMed ID: 1578375
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of a P2T ADP receptor in Xenopus oocytes injected with megakaryocyte (CMK 11-5) RNA.
Greco NJ
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):769-77. PubMed ID: 9108793
[TBL] [Abstract][Full Text] [Related]
13. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
14. Identification of 6H1 as a P2Y purinoceptor: P2Y5.
Webb TE; Kaplan MG; Barnard EA
Biochem Biophys Res Commun; 1996 Feb; 219(1):105-10. PubMed ID: 8619790
[TBL] [Abstract][Full Text] [Related]
15. Identification of a P2X1 purinoceptor expressed on human platelets.
Scase TJ; Heath MF; Allen JM; Sage SO; Evans RJ
Biochem Biophys Res Commun; 1998 Jan; 242(3):525-8. PubMed ID: 9464249
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.
Lazarowski ER; Watt WC; Stutts MJ; Boucher RC; Harden TK
Br J Pharmacol; 1995 Sep; 116(1):1619-27. PubMed ID: 8564228
[TBL] [Abstract][Full Text] [Related]
17. P1- and P2-purinoceptor subtypes--an update.
Kennedy C
Arch Int Pharmacodyn Ther; 1990; 303():30-50. PubMed ID: 2196860
[TBL] [Abstract][Full Text] [Related]
18. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
[TBL] [Abstract][Full Text] [Related]
19. Binding of [35S]adenosine 5'-O-(2-thiodiphosphate) to endothelial cells in culture.
Wilkinson GF; Boarder MR
Biochem Pharmacol; 1995 May; 49(10):1411-8. PubMed ID: 7763284
[TBL] [Abstract][Full Text] [Related]
20. Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy.
Ingall AH; Dixon J; Bailey A; Coombs ME; Cox D; McInally JI; Hunt SF; Kindon ND; Teobald BJ; Willis PA; Humphries RG; Leff P; Clegg JA; Smith JA; Tomlinson W
J Med Chem; 1999 Jan; 42(2):213-20. PubMed ID: 9925726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
